Chaime Orlev — Chief Financial Officer at Kamada Ltd.

Mr. Chaime Orlev has been the Chief Financial Officer of Kamada Ltd. since January 1, 2018. Mr. Orlev has served in senior finance roles for nearly 20 years, with approximately 12 years spent in the life sciences industry. Mr. Orlev served as Chief Financial Officer and Vice President of Finance and Administration at Bioblast Pharma Ltd from 2016 to 2017. He served as Vice President of Finance and Administration at Chiasma, Inc. from December 2011 to January 5, 2016. In this role, he helped lead the company's 2015 $100+ million Initial Public Offering on the NASDAQ stock exchange, as well as participated in the negotiations and closing of the licensing agreement for the company's lead product to F. Hoffmann-La Roche. Mr. Orlev serves as Vice President of Finance and Administration at Chiasma (Israel) Ltd. He served as the Director of Finance at Chiasma (Israel) Ltd. since 2010. He served as the Chief Financial Officer, Secretary and Treasurer of Oramed Pharmaceuticals Inc., from May 1, 2008 to March 31, 2009 and also served as its Principal Accounting Officer until March 31, 2009 and was responsible for oversight of its financial reporting and controls and led multiple capital raises. He served as the Chief Financial Officer of Gammacan International Inc., and its subsidiary, Gammacan Ltd., from October 6, 2005 to February 28, 2008. He served as Treasurer of Gammacan International Inc. from May 22, 2007 to February 28, 2008 and served as its Principal Accounting Officer and Secretary until February 28, 2008. Prior to joining Gammacan, he served as the Chief Financial Officer of Solel Solar Systems from September 2004 to September 2005. He was a Financial Consultant to several Israeli biotech and medical device companies. He served as the Chief Financial Officer and Vice President of Finance of Huntleigh from April 2001 to August 2004. He served as Financial Controller and Acting Chief Financial Officer of ICTS International N.V. from 1999 to 2001. He is a Certified Public Accountant in Israel. Mr. Orlev holds an MBA from the Leon Recanati Graduate School of Business Administration at the Tel Aviv University and a BA in Business Administration from the College of Business in Israel.